Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur - Aix-Marseille Université Access content directly
Journal Articles Médecine/Sciences Year : 2012

Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur

Abstract

The purpose of this review of the literature is to document how breast cancer patients perceive the use of tumor gene profiling approaches to better adapt treatments, and to identify the features of these approaches that may impact their clinical application. In general, the use of tumor genomic analysis was perceived by patients as an approach facilitating personalized medicine and received considerable support. Nevertheless, a number of confusions and worries about these practices were also identified. Improving the quality of provider/patient communications should enable patients to play a more active part in the decision-making about their treatment. This will ensure that those who agree to their tumor gene analysis have realistic expectations and sound deductions of the final result disclosure process.

Domains

Cancer

Dates and versions

hal-03623782 , version 1 (29-03-2022)

Identifiers

Cite

Isabelle Pellegrini, Myrto Rapti, Jean-Marc Extra, Anouk Petri-Cal, Themis Apostolidis, et al.. Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur. Médecine/Sciences, 2012, 28, pp.24-27. ⟨10.1051/medsci/2012281s107⟩. ⟨hal-03623782⟩
5 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More